Access
This article is part of Nature's premium content.
Published online 28 June 2004 | Nature | doi:10.1038/news040621-10
News
Nasal solution joins SARS race
Vaccine against fatal virus works in monkeys.
As human trials of a vaccine for severe acute respiratory syndrome (SARS) kick off in China, US researchers are developing the first nasal vaccine for the disease.
"The nose is where the infection attacks, so it is very effective," says Peter Collins, an infectious disease scientist at the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, who is involved in the study.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.